Aquestive Therapeutics, Inc. (AQST) vs Kamada Ltd. (KMDA)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Kamada Ltd. KMDA 7.77 −0.77%
Aquestive Therapeutics, Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $509.6M against $451.7M — 1.1× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 20.4×. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 13.2%. Kamada Ltd. has the higher net margin (11.6% vs −144.6%) and the higher return on invested capital (8.47% vs 0.00%). Across the 18 metrics below, Kamada Ltd. leads on 13 and Aquestive Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AQST | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 40.82% | 53.94% |
| Operating margin | (97.52%) | 14.51% | 0.00% |
| Net margin | (144.63%) | 11.60% | 0.00% |
| Free cash flow margin | (84.95%) | 13.72% | 0.00% |
| Return on equity | 121.12% | 8.40% | (0.40%) |
| Return on assets | (69.29%) | 5.92% | (3.32%) |
| Return on invested capital | 0.00% | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack